6217 results
-
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 March 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/03/2022 to 10/03/2022, Last updated: 22/11/2022 -
List item
Committee for Orphan Medicinal Products (COMP): 4-6 October 2022
European Medicines Agency, Amsterdam, the Netherlands, from 04/10/2022 to 06/10/2022, Last updated: 17/11/2022 -
List item
Committee for Orphan Medicinal Products (COMP): 8-10 November 2022
European Medicines Agency, Amsterdam, the Netherlands, from 08/11/2022 to 10/11/2022, Last updated: 07/11/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 February 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/02/2022 to 10/02/2022, Last updated: 07/11/2022 -
List item
News: EMA recommends measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders
PRAC, Last updated: 03/11/2022 -
List item
Committee for Orphan Medicinal Products (COMP): 6-8 September 2022
European Medicines Agency, Amsterdam, the Netherlands, from 06/09/2022 to 08/09/2022, Last updated: 21/10/2022 -
List item
Committee for Orphan Medicinal Products (COMP): 12-14 July 2022
European Medicines Agency, Amsterdam, the Netherlands, from 12/07/2022 to 14/07/2022, Last updated: 21/10/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 10-13 January 2022
European Medicines Agency, Amsterdam, the Netherlands, from 10/01/2022 to 13/01/2022, Last updated: 07/10/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 29 November-2 December 2021
European Medicines Agency, Amsterdam, the Netherlands, from 29/11/2021 to 02/12/2021, Last updated: 04/10/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 29 August - 1 September 2022
European Medicines Agency, Amsterdam, the Netherlands, from 29/08/2022 to 01/09/2022, Last updated: 02/09/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 25-28 October 2021
European Medicines Agency, Amsterdam, the Netherlands, from 25/10/2021 to 28/10/2021, Last updated: 02/08/2022 -
List item
Committee for Orphan Medicinal Products (COMP): 14-16 June 2022
European Medicines Agency, Amsterdam, the Netherlands, from 14/06/2022 to 16/06/2022, Last updated: 22/07/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 4-7 July 2022
European Medicines Agency, Amsterdam, the Netherlands, from 04/07/2022 to 07/07/2022, Last updated: 04/07/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 26-29 September 2022
European Medicines Agency, Amsterdam, the Netherlands, from 26/09/2022 to 29/09/2022, Last updated: 04/07/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 24-27 October 2022
European Medicines Agency, Amsterdam, the Netherlands, from 24/10/2022 to 27/10/2022, Last updated: 04/07/2022 -
List item
Committee for Orphan Medicinal Products (COMP): 11-13 April 2022
European Medicines Agency, Amsterdam, the Netherlands, from 11/04/2022 to 13/04/2022, Last updated: 16/06/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 June 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/06/2022 to 10/06/2022, Last updated: 07/06/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 July 2021
European Medicines Agency, Amsterdam, the Netherlands, from 05/07/2021 to 08/07/2021, Last updated: 10/05/2022 -
List item
News: COVID-19: EMA recommends conditional marketing authorisation for Paxlovid
CHMP, PRAC, Last updated: 28/01/2022 -
List item
Committee for Orphan Medicinal Products (COMP): 18-20 January 2022
European Medicines Agency, Amsterdam, the Netherlands, from 18/01/2022 to 20/01/2022, Last updated: 27/01/2022 -
List item
Committee for Orphan Medicinal Products (COMP): 5-7 October 2021
European Medicines Agency, Amsterdam, the Netherlands, from 05/10/2021 to 07/10/2021, Last updated: 14/12/2021 -
List item
Committee for Orphan Medicinal Products (COMP): 7-9 December 2021
European Medicines Agency, Amsterdam, the Netherlands, from 07/12/2021 to 09/12/2021, Last updated: 06/12/2021 -
List item
News: Call for expressions of interest for civil society representatives to participate in work of EMA
PRAC, Last updated: 27/10/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 August – 2 September 2021
PRAC, Last updated: 17/09/2021 -
List item
Committee for Orphan Medicinal Products (COMP): 15-17 June 2021
European Medicines Agency, Amsterdam, the Netherlands, from 15/06/2021 to 17/06/2021, Last updated: 24/06/2021